Many people who feel “late” weren’t lazy—they were busy surviving things no one saw. If you’ve ever looked around and thought ...

Advancing AI threatens S&P Global and Adobe's business moats. Read about why investors should reconsider these stocks here.

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...